The drugs we've got...the drugs we're getting...beyond blood. A three-part look at the Fourth Conference on Retroviruses and Opportunistic Infections. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

J Int Assoc Physicians AIDS Care. 1997 Apr;3(4):9-13, 16-8, 21-40. Unique Identifier : AIDSLINE AIDS/97702490
Mascolini M

Abstract: Some of the most compelling presentations at the Fourth Conference on Retroviruses and Opportunistic Infections were those involving the presence of HIV outside of the blood stream. Other topics discussed included drug-versus-drug studies, antiretroviral therapy for children, and studies showing stavudine plus 3TC as a potent nucleoside combination. A cluster of reports is included with hard data on how nonnucleosides and protease inhibitors might be combined in heavily-pretreated individuals. The conference reports are grouped under three headings: today's drugs, tomorrow's drugs, and tissue studies. Abstract numbers that are available on the World Wide Web are noted in parentheses in the text and tables.

Keywords: Anti-HIV Agents/ADMINISTRATION & DOSAGE/*THERAPEUTIC USE DNA, Viral Disease Transmission, Vertical/PREVENTION & CONTROL Drug Resistance, Microbial/GENETICS Drug Therapy, Combination Female HIV Infections/*DRUG THERAPY/IMMUNOLOGY/VIROLOGY HIV Protease Inhibitors/ADMINISTRATION & DOSAGE/THERAPEUTIC USE HIV-1/DRUG EFFECTS/GENETICS/ISOLATION & PURIF Human Lymphoid Tissue Mucus/VIROLOGY Mutation Patient Compliance Pregnancy Pregnancy Complications, Infectious RNA, Viral/BLOOD Reverse Transcriptase Inhibitors/ADMINISTRATION & DOSAGE/ THERAPEUTIC USE Semen/VIROLOGY Treatment Outcome Vagina/SECRETION Viral Load NEWSLETTER ARTICLE MEETING REPORT
970830
M9781259

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .